{
    "organizations": [],
    "uuid": "72323a31e507ecbdc0e8cc42d3058a909d459d48",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-scpharmaceuticals-reports-qtrly-lo/brief-scpharmaceuticals-reports-qtrly-loss-per-share-of-0-47-idUSASC0A05H",
    "ord_in_thread": 0,
    "title": "scPharmaceuticals Reports Qtrly Loss Per Share Of $0.47",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - scPharmaceuticals Inc:\n* SCPHARMACEUTICALS INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* SCPHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.47 * SCPHARMACEUTICALS INC - EXPECTS THAT ITS EXISTING CASH RESOURCES WILL ENABLE IT TO SUCCESSFULLY FUND OPERATING EXPENSES THROUGH 2019 Source text for Eikon:\nOur ",
    "published": "2018-05-08T04:43:00.000+03:00",
    "crawled": "2018-05-08T16:33:15.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "scpharmaceuticals",
        "inc",
        "scpharmaceuticals",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "scpharmaceuticals",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "scpharmaceuticals",
        "inc",
        "expects",
        "existing",
        "cash",
        "resource",
        "enable",
        "successfully",
        "fund",
        "operating",
        "expense",
        "source",
        "text",
        "eikon"
    ]
}